The Modified Phenanthridine PJ34 Unveils an Exclusive Cell-Death Mechanism in Human Cancer Cells

Cancers (Basel). 2020 Jun 19;12(6):1628. doi: 10.3390/cancers12061628.

Abstract

This overview summarizes recent data disclosing the efficacy of the PARP inhibitor PJ34 in exclusive eradication of a variety of human cancer cells without impairing healthy proliferating cells. Its cytotoxic activity in cancer cells is attributed to the insertion of specific un-repairable anomalies in the structure of their mitotic spindle, leading to mitotic catastrophe cell death. This mechanism paves the way to a new concept of cancer therapy.

Keywords: distorted mitotic spindles; exclusive eradication of human cancer cells; the PARP inhibitor PJ34.

Publication types

  • Review